Don't Miss

Home / Health / Reduced base prices of cardiac stents to be effective from Sept 1

Reduced base prices of cardiac stents to be effective from Sept 1

Abbott Laboratories and Boston Scientific– two of the global leading producers and suppliers of cardiac stents, have agreed to reduce the base prices of several cardiac stents effective from September 1.

Officials of the two companies agreed to the price reduction in a meeting at the Directorate General of Drug Administration (DGDA) in the capital this noon.